drugset / Trial / NCT01042574

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy

NCT01042574

NaSingle-groupOpen-labelTreatment

Summary

This study is a single-arm, open label protocol evaluating the use of Cleviprex to rapidly control hypertension in patients who present with intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH), and that require ICP monitoring via ventriculostomy (External Ventricular Drain or EVD).

Timeline

Start
2010-05
Primary completion
2010-12-31
Completion
2010-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Clevidipine Small molecule 2 mg Intravenous